Microscan Celebrates 20 Years of Data Matrix Codes - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Microscan Celebrates 20 Years of Data Matrix Codes


Microscan, a manufacturer of precision data acquisition and control solutions for automation and OEM applications, celebrates the 20th anniversary of the two-dimensional (2D) data matrix code. Since the invention of data matrix in 1994 by International Data Matrix, Inc. (I.D. Matrix), 2D data matric codes have played an important role in track and trace in manufacturing and production, which includes pharmaceutical products.

A single data matrix code can hold thousands of characters. Its benefits include the compact size, data-carrying capacity and generous reading tolerance. According to Microscan, data matrix can be read at lower contrast ratios than most barcode symbologies, which is advantageous in environments where codes may be obscured and in cases where the code is directly applied to metal and other reflective surfaces through various marking methods.

Data Matrix codes with scratches, tears, or stains can be successfully read without data loss, even if more than 20% of the symbol is damaged, making it the code of choice in data tracking and traceability regulations and standards, such as the FDA and EU regulations for packaging of pharmaceutical products.  

Source: Microscan

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here